Grant: Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
McGill University
$98,218.00
Development of markers for ivermectin resistance in Onchocerca volvulus, the causative agent of River Blindness
EF 2008-09
Résumé
River blindness, or onchocerciasis, is estimated to affect over 37 million people globally. It is caused by the parasitic nematode Onchocerca volvulus. The disease is manifested by blindness and occular impairment in the worst instances and by severe disseminated pruritis and skin pathology. Since 1987, ivermectin has been used as the sole means of chemoprophylaxis requiring annual or semiannual repeated drug treatment at the community level. Ivermectin treatment is not curative, but reduces morbidity and parasite transmission. In some communities and individual over 20 rounds of ivermectin treatment have been administered. Unfortunately, there have been recent reports of developing resistance to ivermectin in O. volvulus. Because the drug has long term effects on reproduction by the parasite and the parasite cannot be be cultured in vitro for any length of time, nor is there an animal model for O. volvulus infection, monitoring for parasite response to treatment is very difficult and there is urgent need for the development of molecular markers for ivermectin resistance in O. volvulus. We have samples of O. volvulus which have been very well characterized in terms of the parasites response to ivermectin. In the proposed research we will use these phenotypically characterized samples to analyse for DNA markers which can be used to monitor for ivermectin resistance. Such markers will be important to identify foci where resistance has developed so that alternative control measures can be applied and for assessing the spread of resistant parasites to other communities.
Programme
Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
183469
Name
Prichard Roger K
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
Development of markers for ivermectin resistance in Onchocerca volvulus, the causative agent of River Blindness
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$98,218
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Keyworddelim
Drug Resistance; Genetic Polymorphism; Molecular Markers For Anthelmintic Resistance; Nematodes; Onchocerciasis; Parasitic Diseases
Abstract
River blindness, or onchocerciasis, is estimated to affect over 37 million people globally. It is caused by the parasitic nematode Onchocerca volvulus. The disease is manifested by blindness and occular impairment in the worst instances and by severe disseminated pruritis and skin pathology. Since 1987, ivermectin has been used as the sole means of chemoprophylaxis requiring annual or semiannual repeated drug treatment at the community level. Ivermectin treatment is not curative, but reduces morbidity and parasite transmission. In some communities and individual over 20 rounds of ivermectin treatment have been administered. Unfortunately, there have been recent reports of developing resistance to ivermectin in O. volvulus. Because the drug has long term effects on reproduction by the parasite and the parasite cannot be be cultured in vitro for any length of time, nor is there an animal model for O. volvulus infection, monitoring for parasite response to treatment is very difficult and there is urgent need for the development of molecular markers for ivermectin resistance in O. volvulus. We have samples of O. volvulus which have been very well characterized in terms of the parasites response to ivermectin. In the proposed research we will use these phenotypically characterized samples to analyse for DNA markers which can be used to monitor for ivermectin resistance. Such markers will be important to identify foci where resistance has developed so that alternative control measures can be applied and for assessing the spread of resistant parasites to other communities.
Competitiondate
200809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Prichard, Roger K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $98,218~ $0~